Your browser doesn't support javascript.
loading
Effectiveness of iconic therapy for the reduction of borderline personality disorder symptoms among suicidal youth: study protocol for a randomised controlled trial.
Hurtado-Santiago, Silvia; Guzmán-Parra, José; Bersabé, Rosa M; Mayoral, Fermín.
Afiliación
  • Hurtado-Santiago S; Saint John of God Psychiatric Centre, Hospitaller Order of Saint John of God, Málaga, Spain. shs@cop.es.
  • Guzmán-Parra J; Mental Health Department, Medical Research Institute (IBIMA) of Málaga, Regional University Hospital of Málaga, Málaga, Spain.
  • Bersabé RM; Department of Psychobiology and Methodology of the Behavioural Sciences Department, University of Málaga, Málaga, Spain.
  • Mayoral F; Mental Health Department, Medical Research Institute (IBIMA) of Málaga, Regional University Hospital of Málaga, Málaga, Spain.
BMC Psychiatry ; 18(1): 277, 2018 09 03.
Article en En | MEDLINE | ID: mdl-30176878
ABSTRACT

BACKGROUND:

Borderline personality disorder (BPD) is associated with an intensive use of mental health services, even in the absence of a full diagnosis. Early symptom detection and intervention may help alleviate adverse long-term outcomes. Iconic Therapy is an innovative manual-driven psychotherapy that treats BPD symptoms in a specific and intensive manner. Preliminary results are promising and the indication is that Iconic Therapy may be effective in reducing BPD symptoms. The aim of this study is to assess how effective Iconic Therapy is compared to Structured Support Therapy in a real clinical setting. METHODS/

DESIGN:

Our study will be a controlled 12-month pragmatic, two-armed RCT. A total of 72 young people (15 to 25 years old) with suicidal ideation/self-injuring behaviour and BPD traits and symptoms will participate in the study. The subjects will be randomised into two groups Iconic Therapy or Structured Support Therapy. The participants will be assigned to either group on a 11 basis. Both the Iconic Therapy and the Structured Support Therapy programmes consist of 11 weekly sessions delivered by two trained psychologists in a group format of between 8 to 12 outpatients. The primary outcome will be measured by the change in symptom severity. Secondary outcomes include changes in suicidal ideation/ behaviour, non-suicidal self-injury, maladjustment to daily life and cost-effective analysis. The primary outcome will be a decrease in the severity of BPD symptoms as assessed by the Borderline Symptom List (BSL-23). For the clinical evaluation, three study assessments will take place at baseline, after treatment and at 12-month follow-up. We hypothesise that patients attending the Iconic Therapy group will show a significantly higher reduction in symptoms than those in the Structured Support Therapy group. Data will be analysed using generalised estimating equation (GEE) models.

DISCUSSION:

By responding to the need for briefer and more comprehensive therapies for BPD, we foresee that Iconic Therapy may provide an alternative treatment whose specific therapeutic principles, visually represented on icons, will overcome classical Structured Support Therapy at reducing BPD symptoms. TRIAL REGISTRATION NCT03011190.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Psicoterapia / Psicoterapia de Grupo / Trastorno de Personalidad Limítrofe / Ensayos Clínicos Controlados Aleatorios como Asunto Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Límite: Adolescent / Adult / Female / Humans / Male Idioma: En Revista: BMC Psychiatry Asunto de la revista: PSIQUIATRIA Año: 2018 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Psicoterapia / Psicoterapia de Grupo / Trastorno de Personalidad Limítrofe / Ensayos Clínicos Controlados Aleatorios como Asunto Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Límite: Adolescent / Adult / Female / Humans / Male Idioma: En Revista: BMC Psychiatry Asunto de la revista: PSIQUIATRIA Año: 2018 Tipo del documento: Article País de afiliación: España